Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11
This article describes ferroptosis as a previously unappreciated mechanism of action for
radiotherapy. Further, it shows that ferroptosis is a novel point of synergy between …
radiotherapy. Further, it shows that ferroptosis is a novel point of synergy between …
[HTML][HTML] Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma
DR Wahl, MH Stenmark, Y Tao, EL Pollom… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
… Analyses were performed using R (version 3.1.1; R Foundation for Statistical Computing,
Vienna, Austria). … Collection and assembly of data: Daniel R. Wahl, Matthew H. Stenmark …
Vienna, Austria). … Collection and assembly of data: Daniel R. Wahl, Matthew H. Stenmark …
[HTML][HTML] GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
…, T Daubon, F Cheng, CA Lyssiotis, DR Wahl… - Nature cancer, 2023 - nature.com
The transfer of intact mitochondria between heterogeneous cell types has been confirmed
in various settings, including cancer. However, the functional implications of mitochondria …
in various settings, including cancer. However, the functional implications of mitochondria …
[HTML][HTML] Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced …
…, M Wei, J Yun, MC Hung, W Zhou, DR Wahl… - The Lancet Digital …, 2022 - thelancet.com
Background Accurate prediction of tumour response to neoadjuvant chemoradiotherapy
enables personalised perioperative therapy for locally advanced rectal cancer. We aimed to …
enables personalised perioperative therapy for locally advanced rectal cancer. We aimed to …
[HTML][HTML] Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
…, TS Lawrence, CA Lyssiotis, DR Wahl - Nature …, 2020 - nature.com
Intratumoral genomic heterogeneity in glioblastoma (GBM) is a barrier to overcoming therapy
resistance. Treatments that are effective independent of genotype are urgently needed. By …
resistance. Treatments that are effective independent of genotype are urgently needed. By …
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease
E Gatza, DR Wahl, AW Opipari, TB Sundberg… - Science translational …, 2011 - science.org
Cells generate adenosine triphosphate (ATP) by glycolysis and by oxidative phosphorylation
(OXPHOS). Despite the importance of having sufficient ATP available for the energy-…
(OXPHOS). Despite the importance of having sufficient ATP available for the energy-…
Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy
This study demonstrates that ATM inhibition induces a T1IFN-mediated innate immune
response in pancreatic cancer that is further enhanced by radiation and leads to increased …
response in pancreatic cancer that is further enhanced by radiation and leads to increased …
[PDF][PDF] Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas
H3K27M diffuse intrinsic pontine gliomas (DIPGs) are fatal and lack treatments. They mainly
harbor H3.3K27M mutations resulting in H3K27me3 reduction. Integrated analysis in H3.…
harbor H3.3K27M mutations resulting in H3K27me3 reduction. Integrated analysis in H3.…
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
DR Wahl, CA Byersdorfer, JLM Ferrara… - Immunological …, 2012 - Wiley Online Library
For several decades, it has been known that T‐cell activation in vitro leads to increased
glycolytic metabolism that fuels proliferation and effector function. Recently, this simple model …
glycolytic metabolism that fuels proliferation and effector function. Recently, this simple model …
[PDF][PDF] Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
Effective therapies are lacking for patients with advanced colorectal cancer (CRC). The CRC
tumor microenvironment has elevated metabolic waste products due to altered metabolism …
tumor microenvironment has elevated metabolic waste products due to altered metabolism …